96 related articles for article (PubMed ID: 2805953)
21. [Clinical investigation of urinary dipeptidyl aminopeptidase IV (DAP IV) activity in patients with primary glomerular diseases].
Nagata T
Nihon Jinzo Gakkai Shi; 1990 Nov; 32(11):1161-8. PubMed ID: 1982015
[TBL] [Abstract][Full Text] [Related]
22. [Effect of total saponins of Panax notoginseng on urinary albumin in patients with chronic renal failure].
Peng SL; Guo ZA
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2010 Dec; 22(12):744-6. PubMed ID: 21190603
[TBL] [Abstract][Full Text] [Related]
23. Monoclonal antibody 1-22-3-induced glomerulonephritis in uninephrectomized rats as a model of progressive renal failure.
Tomita M; Sogabe H; Nakazato S; Nakatsuji S; Noto T; Hamada K; Kawachi H; Shimizu F; Matsuo M; Mutoh S
Nephrol Dial Transplant; 2005 Nov; 20(11):2358-67. PubMed ID: 16091375
[TBL] [Abstract][Full Text] [Related]
24. [Effect of angiotensin II receptor antagonist (losartan) on renal function, serum potassium and blood pressure in patients with advanced renal failure: differences between patients with a serum creatinine (SCr) level higher than 3 mg/dl and those with a lower SCr level].
Nakayama M; Tanno Y; Otsuka Y; Takahashi H; Ikeda M; Katoh N; Yokoyama K; Yamamoto H; Tokutome G; Hosoya T
Nihon Jinzo Gakkai Shi; 2002 Oct; 44(7):530-6. PubMed ID: 12476589
[TBL] [Abstract][Full Text] [Related]
25. Effect rHuEpo on predialysis CRF patients: study of 45 cases.
Islam S; Rahman H; Rashid HU
Bangladesh Med Res Counc Bull; 2005 Aug; 31(2):83-7. PubMed ID: 16967814
[TBL] [Abstract][Full Text] [Related]
26. [Comparison of the efficacy of intravenous urokinase and defibrase on 6-hour-old canine coronary thrombosis].
Huang DX; Song AL; Yang XS
Zhonghua Xin Xue Guan Bing Za Zhi; 1988 Dec; 16(6):363-5, 384. PubMed ID: 3248518
[No Abstract] [Full Text] [Related]
27. Comparison of progression of renal failure in children with hypoplastic-dysplastic kidneys and chronic glomerulonephritis.
Chao SM; Saw AH; Yap HK; Tan SP; Murugasu B; Tay AH
Singapore Med J; 1991 Oct; 32(5):304-6. PubMed ID: 1788570
[TBL] [Abstract][Full Text] [Related]
28. The effect of enalapril on proteinuria in patients with chronic glomerulonephritis and renal insufficiency.
Yoshida A; Morozumi K; Takeda A; Koyama K; Ideura T; Ikeda M; Oikawa T
Nihon Jinzo Gakkai Shi; 1993 Nov; 35(11):1249-52. PubMed ID: 8139137
[TBL] [Abstract][Full Text] [Related]
29. Immune complex-mediated glomerulonephritis is ameliorated by thrombin-activatable fibrinolysis inhibitor deficiency.
Bruno NE; Yano Y; Takei Y; Qin L; Suzuki T; Morser J; D'Alessandro-Gabazza CN; Mizoguchi A; Suzuki K; Taguchi O; Gabazza EC; Sumida Y
Thromb Haemost; 2008 Jul; 100(1):90-100. PubMed ID: 18612543
[TBL] [Abstract][Full Text] [Related]
30. Effect of erythropoietin on urinary liver-type fatty-acid-binding protein in patients with chronic renal failure and anemia.
Nakamura T; Sugaya T; Kawagoe Y; Suzuki T; Ueda Y; Koide H
Am J Nephrol; 2006; 26(3):276-80. PubMed ID: 16772708
[TBL] [Abstract][Full Text] [Related]
31. [Prediction of accelerated progression of chronic glomerulonephritis basing on clinical and histomorphological data].
Ratner MIa; Stenina II; Fedorova ND
Ter Arkh; 1999; 71(6):27-30. PubMed ID: 10420451
[TBL] [Abstract][Full Text] [Related]
32. [Chromosome aberration levels and their dynamics during the treatment with cytotoxic preparations of patients with primary and lupus glomerulonephritis].
Diadyk AI; Sokhin AA; Siniachenko OV; Efremenko VA; Bagriĭ AE; Nikolenko IuI; Iarovaia NF; Nikolenko VIu
Ter Arkh; 1991; 63(8):84-8. PubMed ID: 1792627
[TBL] [Abstract][Full Text] [Related]
33. Protein intake of more than 0.5 g/kg BW/day is not effective in suppressing the progression of chronic renal failure.
Ideura T; Shimazui M; Morita H; Yoshimura A
Contrib Nephrol; 2007; 155():40-49. PubMed ID: 17369712
[TBL] [Abstract][Full Text] [Related]
34. [Clinico-morphologic analysis of compensatory and adaptive processes of the kidneys in chronic glomerulonephritis].
Zufarov AK
Ter Arkh; 1989; 61(6):73-5. PubMed ID: 2799721
[TBL] [Abstract][Full Text] [Related]
35. [Clinical implications of urine matrix metalloproteinases and their inhibitors in patients with chronic glomerulonephritis].
Li OA; Bobkova IN; Kozlovckaia LV
Ter Arkh; 2009; 81(8):10-4. PubMed ID: 19799193
[TBL] [Abstract][Full Text] [Related]
36. [The effect of angiotensin-converting enzyme inhibitors on proteinuria in chronic glomerulonephritis].
Erley CM; Komini E; Nicaeus T; Braun N; Wolf S; Risler T
Dtsch Med Wochenschr; 1994 Jan; 119(4):89-95. PubMed ID: 8299527
[TBL] [Abstract][Full Text] [Related]
37. Protective effect of an oral adsorbent on renal function in chronic renal failure: determinants of its efficacy in diabetic nephropathy.
Sanaka T; Akizawa T; Koide K; Koshikawa S
Ther Apher Dial; 2004 Jun; 8(3):232-40. PubMed ID: 15154877
[TBL] [Abstract][Full Text] [Related]
38. [Clinical effect of treatment with lipo-prostaglandin E1 on the patients with chronic glomerulonephritis].
Zhong WQ; Liu GX; Yang YM; Cai X; Huang ZL
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 May; 16(5):292-4. PubMed ID: 15132795
[TBL] [Abstract][Full Text] [Related]
39. Optimized project of traditional Chinese medicine in treating chronic kidney disease stage 3: a multicenter double-blinded randomized controlled trial.
Wang YJ; He LQ; Sun W; Lu Y; Wang XQ; Zhang PQ; Wei LB; Cao SL; Yang NZ; Ma HZ; Gao J; Li P; Tao XJ; Yuan FH; Li J; Yao C; Liu X
J Ethnopharmacol; 2012 Feb; 139(3):757-64. PubMed ID: 22178174
[TBL] [Abstract][Full Text] [Related]
40. [A new treatment of hyperkalemia in renal failure with selective beta 2-adrenergic stimulant, terbutaline sulfate].
Tanaka Y; Nagao M; Nishio T; Hashida E; Kashiwagi A; Shigeta Y
Nihon Jinzo Gakkai Shi; 1989 Apr; 31(4):353-8. PubMed ID: 2747008
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
